Skip to main content
. Author manuscript; available in PMC: 2016 Nov 11.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):579–584. doi: 10.1097/QAI.0000000000001019

Table 2.

Characteristics of women who transmitted HIV to male partners while on ART

Variable Couple 1 Couple 2 Couple 3
Couple demographics (age, gender) 40M, 50F 53M, 31F 32M, 29F
Enrollment plasma HIV RNA (copies/mL) 332,514 20,188 694
Pre-ART plasma HIV RNA (copies/mL) 1,434,082 56,168 824
Time from enrollment to ART initiation (months) 14 22 25
ART regimen AZT/3TC/NVP TDF/3TC/NVP d4T/3TC/NVP
Time from reported date of ART initiation to HIV seroconversion (days) 56 0 149
Time from reported date of ART initiation to HIV RNA quantification (days) 84 28 86
Post ART plasma HIV RNA (copies/mL)
 ≤6 months
 >6 months

738
<80

404
160

872
264
Post ART endocervical HIV RNA (copies/swab)
 ≤6 months
 >6 months

<248*
<248

3166
<248

No samples
available